Dynocardia is 1 of 19 finalists chosen to pitch at the $200K Challenge Pitch-Off last Wednesday. Dynocardia’s ViTrack™ is the first-of-its-kind, standalone, cuff-less, wearable device for continuous non-invasive blood pressure monitoring.
Mohan Thanikachalam, CEO of Dynocardia, offers us an exclusive inside look behind the development of the ViTrackTM!
Read moreWe’re thrilled to welcome Johnson & Johnson Innovation’s V. Kadir Kadhiresan as the keynote speaker for the $200K Challenge Award Celebration on 4/10 in Boston!
Continue reading
On Wednesday night, nearly 250 attendees—life sciences innovators, investors, researchers, academics, and students—gatheredin UMass Lowell’s Maloney hall for the 2019 M2D2 $200K Challenge Pitch-Off.
Continue reading
Top Row, Left to Right: Ragul Puhazhendi, Suha Sudharsanan, and Shiva Prakash of BuzzArk; Bottom Row, Left to Right: Vasanth Raghava, Prof S P Thyagarajan, Dr. T Mohanapriya, and Dr. Ramesh Sadasivan of BuzzArk
BuzzArk Simulations, chosen for their development of a VR simulation for natural orifice surgery procedures, is 1 of 20 MedTech startup finalists in the 8th annual M2D2 $200K Challenge.
Ragul Puhazhendi, Founder of Buzzark, offers us an exclusive inside look at the ups and downs behind the development of their simulation technology.
Margot Damaser, Full Staff and Professor at the Department of Biomedical Engineering for The Cleveland Clinic
The UroMonitor, a device to simplify and improve the diagnosis and treatment of stress urinary incontinence, was chosen as 1 of 20 finalists in the 8th annual M2D2 $200K Challenge.
Margot Damaser of Cleveland Clinic leads a team in the development of the UroMonitor. In this article, Margot offers some insight into the background of the innovative device and what it’s taken her team to get it this far!
From left to right, Sabarish RC, Dr. Adith Chinnaswami, and Jeno Manickam of MediSim VR.
MediSim VR, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen to compete for their development of a Haptic enabled VR (virtual reality) surgery simulator.
Co-founder, Dr. Adith Chinnaswami, offers an exclusive inside look about this team’s innovation, background, and future plans.
James McNamara, Scientific Founder and CEO of Nuclease Probe Technologies
Nuclease Probe Technologies, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen for their development of a novel diagnostic for accurate and early detection of bloodstream infections (BSI’s).
We spoke with Scientific Founder and CEO, James McNamara, who shared the story of their innovation with us.
Randy Werneth, CEO and President of CardioCorX
Introducing CardioCorX, one of 21 MedTech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO and President, Randy Werneth, who shared the story of their innovation.
CardioCorX was chosen for their development of a simple integrative medical approach for patients suffering from atrial fibrillation with or without heart failure.
Daniel Burnett, Evan Luxon, and Eric Kriegstein of Respirix.
Introducing Respirix, one of 21 medtech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO Eric Kriegstein who shared the story of their innovation.
Respirix is developing a hardware and software platform to change the paradigm for non-invasively monitoring, and managing, patient health.
21 finalists have been selected from over 150 applicants for the 8th Annual M2D2 $200K Challenge. This year’s participation sets a new record for the competition!
LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 8th annual $200K Challenge after reviewing a record-setting 150+ applications. Continue reading